Provided by Tiger Fintech (Singapore) Pte. Ltd.

Nexalin Technology, Inc.

2.15
+0.200010.26%
Post-market: 2.220.0700+3.26%19:18 EDT
Volume:116.83K
Turnover:245.10K
Market Cap:27.65M
PE:-3.22
High:2.20
Open:1.96
Low:1.96
Close:1.95
Loading ...

Nexalin Technology’s Strong Financial Position: No Defaults on Senior Securities

TIPRANKS
·
10 Nov 2024

Retail investors among Nuix Limited's (ASX:NXL) largest shareholders, saw gain in holdings value after stock jumped 6.1% last week

Simply Wall St.
·
05 Nov 2024

Calculating The Fair Value Of Nuix Limited (ASX:NXL)

Simply Wall St.
·
04 Nov 2024

Nuix Ltd. (NXL) Gets a Buy from Shaw and Partners

TIPRANKS
·
02 Nov 2024

Join Nexalin Technology’s Exclusive Live Investor Webinar and Q&A Session on November 5th

GlobeNewswire
·
02 Nov 2024

Nexalin Technology regains compliance with Nasdaq continued listing rules

TIPRANKS
·
01 Nov 2024

Nexalin Technology Regains Nasdaq Compliance Over Minimum Bid Price; Shares Rise

MT Newswires Live
·
01 Nov 2024

BRIEF-Nexalin Technology Regains Compliance With Nasdaq Continued Listing Requirements

Reuters
·
01 Nov 2024

Nexalin Technology Regains Compliance With Nasdaq Continued Listing Requirements

THOMSON REUTERS
·
01 Nov 2024

Nexalin announces study on AD, DIFS published in Journal of Alzheimer’s Disease

TIPRANKS
·
28 Oct 2024

EXCLUSIVE: Nexalin Technology Says New Data Confirms Implantable Device Improves Cognitive Function, Restores Brain Activity in Alzheimer's Patients

Benzinga
·
28 Oct 2024

Nexalin Technology Shares Rise After Clinical Trial Set for Halo Headset in Traumatic Brain Injuries

MT Newswires Live
·
23 Oct 2024

Nexalin announced planned clinical trial utilizing Gen-3 Halo headset

TIPRANKS
·
23 Oct 2024

Nexalin Technology Announces Planned Clinical Trial Utilizing Gen-3 Halo Headset in Partnership With Uc San Diego & San Diego Va

THOMSON REUTERS
·
23 Oct 2024

New Study Shows Nexalin’s Deep Intracranial Frequency Stimulation (DIFS) Significantly Improves Memory and Cognitive Function in Alzheimer’s Patients

GlobeNewswire
·
17 Oct 2024

EXCLUSIVE: Nano-Cap Nexalin's Drug-Free Alternative For Alzheimer's Shows Improved Memory, Cognitive Function In Small Study

Benzinga
·
17 Oct 2024